Category: News
-
How do oncologists in LMICs make treatment decisions? – Now available on YouTube
Our inaugural BG Lab Webinar, How do oncologists in LMICs make treatment decisions?, is now available to watch on YouTube. Dr. Gyawali was joined by Dr. Bhawna Sirohi from Balco Medical Center in Raipur, India, and Dr. Soumitra Datta from Tata Medical Center in Kolkata, India, to discuss how clinicians in LMICs weigh quality of…
-
Dr. Bishal Gyawali speaks with CBC News about prostate cancer screening in Canada
Dr. Bishal Gyawali spoke with CBC The National for a news video and CBC News for an article about new research that suggests prostate cancer cases have increased after screening guidelines changed in the US. However, some experts dispute how this research has been interpreted, and whether guidelines should change. You can watch both the…
-
New study highlights significant variation in the prices of gastrointestinal cancer treatments in Nepal’s public sector
13 November 2025 – A new study published in JCO Global Oncology led by researchers at the National Academy of Medical Sciences (NAMS), Nepal and Bishal Gyawali Lab (BG Lab), Queen’s University highlights significant variation in the price and availability of gastrointestinal cancer drugs within Nepal’s public sector. The co-first authors of this paper are…
-
General Practitioners in Oncology (GPO) Fellowship Program Officially Launched in Nepal
November 4, 2025. The General Practitioners in Oncology (GPO) Fellowship Program has officially launched in Nepal, a collaborative initiative between the National Academy for Medical Sciences (NAMS) and Queen’s University (Canada). The development of the program was led by Dr. Gyawali, and Dr. Bishesh Sharma Poudyal. The program aims to equip general practitioners with the…
-
Webinar: How do Oncologists in LMICs Make Treatment Decisions?
How do oncologists in LMICs like India make treatment decisions? Join our expert panel as we discuss the role of quality of evidence, magnitude of benefit, drug prices, FDA Approval status and clinical practice guidelines in treatment decision making. Discussions will be based on our recent publications in the BMJ Oncology, and ESMO Open. Meeting…
-
ESMO 2025 Highlights & Analysis with Dr. Bishal Gyawali
October 23, 2025 – ecancer published its 10th annual ESMO Congress recap with Dr. Bishal Gyawali. In this video, Dr. Gyawali shares insights on the most noteworthy items to come out of the 2025 ESMO Congress in Berlin, Germany. Highlights include:
-
Dr. Bishal Gyawali speaks with CBC News about Ontario’s new funding program to expedite access to cancer drugs
Dr. Bishal Gyawali spoke with CBC News about Ontario’s new Funding Accelerated for Specific Treatments (FAST) program to expedite access to cancer drugs. Listen via the podcast or read the article. While faster access is welcome, Dr. Gyawali has highlighted several important considerations. The pilot program will apply to 7-10 drugs per year for 3…
-
24th WHO Essential Medicines List Released
The 24th version of the World Health Organization’s (WHO) List of Essential Medicines (EML) and the 10th version of the WHO List of Essential Medicines for Children (EMLc) were released on September 5th, 2025. The WHO EML and EMLc are updated every two years and contain medicines that are considered to be the most safe…
-
Anita Gyawali-Ganesh Gyawali Health Research Award 2025
We are delighted to present the Anita Gyawali-Ganesh Gyawali Health Research Award to Dr. Nitesh Kumar Karna. Dr. Nitesh Kumar Karna is a 3rd-year medical student from BPKIHS, whose research has been accepted as an oral abstract presentation at the prestigious European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The award was…
-
Dr. Bishal Gyawali Receives the 2024 William E. Rawls Prize
Dr. Bishal Gyawali was announced as one of the 2024 Canadian Cancer Society Awards for Excellence recipients. He received the 2024 William E. Rawls Prize for outstanding achievements in cancer control research (early career). The William E. Rawls Prize recognizes early-career investigators whose work has provided significant and importance advancements in cancer control. This award…
